We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
RBC Life Sciences Inc (CE) | USOTC:RBCL | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000067 | 0.00 | 00:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
RBC Life Sciences, Inc.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
74926T201
(CUSIP Number)
December 31, 2014
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ | Rule 13d-1(b) |
x | Rule 13d-1(c) |
¨ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 74926T201
1. |
NAME OF REPORTING PERSONS
I.R.S. Identification Nos. of Above Persons (entities only) Peter J. Abrahamson
| ||
2. |
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ¨ (b) o
| ||
3. |
SEC USE ONLY
| ||
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION United States of America
| ||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5. |
SOLE VOTING POWER 141,500
| |
6. |
SHARED VOTING POWER 0
| ||
7. |
SOLE DISPOSITIVE POWER 141,500
| ||
8.
|
SHARED DISPOSITIVE POWER 0
| ||
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
141,500
| ||
10. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) o | ||
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.4%
| ||
12.
|
TYPE OF REPORTING PERSON (See Instructions)
IN
| ||
ITEM 1
(a) | NAME OF ISSUER RBC Life Sciences, Inc. |
(b) | ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES |
2301 Crown Court
Irving, TX 75038
ITEM 2
(a) | NAME OF PERSON FILING Peter J. Abrahamson |
(b) | ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE |
24156 N. Coventry Ln
Lake Barrington, IL 60010-7334
(c) | CITIZENSHIP United States of America |
(d) | TITLE OF CLASS OF SECURITIES Common Stock |
(e) | CUSIP NUMBER 74926T201 |
ITEM 3
If this statement is filed pursuant to rule 240.13d- 1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
(a) | ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
(b) | ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
(c) | ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
(d) | ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
(e) | ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E) |
(f) | ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F) |
(g) | ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G) |
(h) | ¨ A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). |
(i) | ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). |
(j) | ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(J) |
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 141,500
(b) Percent of class: 6.4%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 141,500
(ii) Shared power to vote or to direct the vote: 0
(iii) Sole power to dispose or to direct the disposition of: 141,500
(iv) Shared power to dispose or to direct the disposition of: 0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
NOT APPLICABLE
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
NOT APPLICABLE
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
NOT APPLICABLE
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
NOT APPLICABLE
ITEM 10. CERTIFICATION.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 6, 2015 | ||
Date | ||
/s/ Peter J. Abrahamson | ||
Signature | ||
Peter J. Abrahamson, Private Investor | ||
Name/Title | ||
1 Year RBC Life Sciences (CE) Chart |
1 Month RBC Life Sciences (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions